MYC Inhibition Found to Be Anti-Metastatic in Breast Cancer
In a new study, researchers demonstrate how MYC inhibition by Omomyc dramatically reduces both primary and metastatic growth in breast cancer.
Israel General Laura Soucek Hebron Institute Of Oncology Cancer Research Communications Models Of Cancer Therapies Group Vall Hebron Institute
Source: genengnews.com